LFB is present at the ISTH international congress

LFB will be present at the ISTH international congress with a symposium on Sunday 18th of July, and several posters’ presentations on Saturday 17^th.

PERSEPT studies posters presentations from Prof. Giancarlo Castaman, Prof. Wolfgang Miesbach, and Prof. Johnny Mahlangu’s are available all day on Saturday 17^th, at the ISTH congress.

• Prof. Giancarlo Castaman presents a prospective study in pediatric haemophilia A & B patients with inhibitors. “Bleed control in children with hemophilia A and B with inhibitors is a real challenge.”  New clinical data to be released at the ISTH congress.

• Prof. Wolfgang Miesbach’s presentation: Hemostatic response and timely resolution of symptoms are a must have for patients living with Hemophilia A & B . “Pain relief in Hemophilia A & B patients with inhibitors is a major goal.”

• Prof. Johnny Mahlangu’s presentation: the safety of a novel treatment for hemophilia A & B patients with inhibitors. “Pooled safety analysis of 3 prospective Phase III studies.”

Come and join Dr. Jean-Luc Plantier’s oral presentation on Monday July 19^th at 11 AM US EDT / 5 PM CET, to discover more about the tissue factor-independent mechanism of action of a novel treatment at the ISTH congress.

The LFB’s Symposium at @ISTH international congress: listen to Profs Giancarlo Castaman, Steven Pipe, Janna Journeycake and Miguel Escobar presentations on Sunday July 18th, 2021 and discover new data in congenital hemophilia A & B patients with inhibitors.